Skyrizi 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FX52V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,094
Award facts
- Contract value 100% obligated
- $24,094.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $24.1K to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml syringes. The contract, awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a firm fixed-price delivery under a competitively awarded, non-set-aside procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $1 billion pharmaceutical supply agreement running through December 2026 that enables AmerisourceBergen to fulfill a broad range of pharmaceutical and medical supply requirements for military and federal healthcare systems globally.
As a major pharmaceutical distributor, AmerisourceBergen maintains a substantial portfolio of federal medical contracts with the DLA Medical Supply Chain, supplying specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The current delivery order for SKYRIZI—a biologic medication used in dermatological treatment—reflects the company's role as a critical vendor for specialized pharmaceutical procurement. This transaction demonstrates AmerisourceBergen's capability to meet federal requirements through open competition and positions the company as a potential awardee under the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V regional contracts, which anticipate multiple contractor awards.
Quick answers
Who was awarded contract SPE2DB25FX52V?
SPE2DB25FX52V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FX52V worth?
The government has obligated $24,094 on SPE2DB25FX52V.
Is contract SPE2DB25FX52V an order under another contract?
Yes. SPE2DB25FX52V is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX52V competed?
The extent of competition for SPE2DB25FX52V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award